MiR-663a is reported to induce immune dysregulation [15] and to suppress proliferation, migration, and invasion of papillary thyroid carcinoma [16], glioblastoma [17], and lung cancer [18] cells via targeting TGF-β1 [15–18]. Here, TGFB1 is linked to thyroid gland papillary carcinoma.